Skip to main content
. Author manuscript; available in PMC: 2023 Apr 24.
Published in final edited form as: Mol Diagn Ther. 2022 Dec 13;27(2):129–140. doi: 10.1007/s40291-022-00625-y

Table 2.

Viral vectors to deliver genes into injured hearts.

Virus Target gene Species Reference
Adenovirus VEGF-DΔNΔC Human [100]
Adenylyl cyclase 6 Human [101]
VEGF, Angiopoietin-1 Pig [102]
Proline/arginine-rich peptide 39 Pig [103]
FGF4 Pig, Human [104, 105]
VEGF121 Human [106]
Cyclin A2 Pig [107]
Cyclin D1, CDK4 Rat [108]
CDK1, CDK4, Cyclin B1, Cyclin D1 Mouse [21]
AAV SERCA2a Human [115]
BNP116 Human ClnicalTrials.gov Identifier: NCT04179643
Glycoprotein 130 Mouse [116]
miRNA-LRP6 Mouse [117]
Lysophosphatidic acid 3 Mouse [118]
miR-199a Pig [119]
Lentivirus miR302–367 Mouse [127]
CDK1, CDK4, CyclinB1, CyclinD1 Rat, Pig [128]
Integrin β1 Rat [129]

AAV, adeno-associated virus; VEGF, vascular endothelial growth factor; FGF, fibroblast growth factor; CDK, cyclin-dependent kinases; SERCA2a, sarcoplasmic/endoplasmic reticulum Ca2+-ATPase; LRP6, low-density lipoprotein receptor-related protein 6.